Oncology
1 drug is in development for Choroidal Melanoma.
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Choroidal Melanoma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Bel-sar | Aura Biosciences, Inc. (AURA) |
About this indication
Choroidal Melanoma context
Oncology·MeSH: Uveal Melanoma (D000098943)
Narrower concept of MeSH descriptor Uveal Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Choroidal Melanoma?
BioSniper tracks 1 drug in development for Choroidal Melanoma across 1 company.
How many clinical trials target Choroidal Melanoma?
There are 5 clinical trials targeting Choroidal Melanoma tracked by BioSniper.
What is the prevalence of Choroidal Melanoma?
The estimated prevalence of Choroidal Melanoma is approximately 75.0 per 100,000 population.